BRD2 encoding a BET transcription factor, which enhances IKK activity and NF-κB activation in ABC-DLBCL in vitro and in vivo [45], was significantly upregulated in c-Rel+ GCB-DLBCL. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.